Neurologic complications in renal transplantation

Area of Science:

• Nephrology
• Neurology
• Transplant Medicine

Background:

• Neurologic complications occur in 10-21% of kidney transplant recipients, significantly higher than the general population.
• Predisposing factors include polypharmacy, reduced cellular immunity, accelerated atherosclerosis, and metabolic abnormalities.
• Immunosuppressive therapy, particularly calcineurin inhibitors, can cause a spectrum of neurological side effects.

Purpose of the Study:

• To review the common and unusual neurologic complications following kidney transplantation.
• To discuss the clinical presentation, predisposing factors, and management strategies for these complications.
• To highlight the impact of immunosuppression on the central nervous system in transplant patients.

Main Methods:

• Literature review of neurologic complications in kidney transplant recipients.
• Analysis of predisposing factors, clinical presentations, and treatment approaches.
• Focus on side effects of immunosuppressive drugs, infections, malignancies, and cerebrovascular events.

Main Results:

• Calcineurin inhibitor-related side effects range from tremors to PRES, often reversible with dose adjustment.
• Central nervous system infections may present subtly due to immunosuppression, with bacterial infections being most common but unusual pathogens also significant.
• Brain malignancies (lymphomas, metastases) and stroke (prevalence ~8%) are increased, influenced by factors like age, diabetes, and vascular disease.

Conclusions:

• Kidney transplant recipients are at increased risk for diverse neurologic complications.
• Management requires careful monitoring of immunosuppression, prompt diagnosis of infections and malignancies, and control of vascular risk factors.
• Understanding these risks is essential for optimizing patient care and outcomes post-transplant.